Furthermore, a combination of A. actinomycetemcomitans-derived CDT with CD133 monoclonal antibody inhibited the proliferation of the aggressive CD133+ ve oral cancer stem cells (Damek-Poprawa et al. 2011). The gene discussed is PROM1; the disease is lip and oral cavity carcinoma.